Levels of Alkaline Phosphatase and Bilirubin are Surrogate Endpoints of Outcomes of Patients with Primary Biliary Cirrhosis – an International Follow-up Study Short title : Alkaline phosphatase and bilirubin as surrogate endpoints in PBC

Citation for published version (Harvard): Lammers, WJ, van Buuren, HR, Hirschfield, GM, Janssen, HLA, Invernizzi, P, Mason, AL, Ponsioen, CY, Floreani, A, Corpechot, C, Mayo, MJ, Battezzati, PM, Parés, A, Nevens, F, Burroughs, AK, Kowdley, KV, Trivedi, PJ, Kumagi, T, Cheung, A, Lleo, A, Imam, MH, Boonstra, K, Cazzagon, N, Franceschet, I, Poupon, R, Caballeria, L, Pieri, G, Kanwar, PS, Lindor, KD, Hansen, BE & Global PBC Study Group 2014, 'Levels of alkaline phosphatase and bilirubin are surrogate end points of outcomes of patients with primary biliary cirrhosis: an international follow-up study' Gastroenterology, vol. 147, no. 6, pp. 1338-49.e5; quiz e15. DOI: 10.1053/j.gastro.2014.08.029

[1]  G. Alexander,et al.  Sex and age are determinants of the clinical phenotype of primary biliary cirrhosis and response to ursodeoxycholic acid. , 2013, Gastroenterology.

[2]  T. Fleming,et al.  Biomarkers and surrogate endpoints in clinical trials , 2012, Statistics in medicine.

[3]  F. Carrat,et al.  Noninvasive elastography‐based assessment of liver fibrosis progression and prognosis in primary biliary cirrhosis , 2012, Hepatology.

[4]  O. Chazouilleres,et al.  Early primary biliary cirrhosis: biochemical response to treatment and prediction of long-term outcome. , 2011, Journal of hepatology.

[5]  K. Lindor,et al.  Optimizing biochemical markers as endpoints for clinical trials in primary biliary cirrhosis , 2011, Liver international : official journal of the International Association for the Study of the Liver.

[6]  T. Arenovich,et al.  Baseline Ductopenia and Treatment Response Predict Long-Term Histological Progression in Primary Biliary Cirrhosis , 2010, The American Journal of Gastroenterology.

[7]  K. V. van Erpecum,et al.  Improved prognosis of patients with primary biliary cirrhosis that have a biochemical response to ursodeoxycholic acid. , 2009, Gastroenterology.

[8]  Y. Chrétien,et al.  Biochemical response to ursodeoxycholic acid and long‐term prognosis in primary biliary cirrhosis , 2008, Hepatology.

[9]  B. Hansen,et al.  Prognosis of Ursodeoxycholic Acid-Treated Patients with Primary Biliary Cirrhosis. Results of a 10-Yr Cohort Study Involving 297 Patients , 2006, The American Journal of Gastroenterology.

[10]  Liang Zhu,et al.  Long-Term Effects of Mid-Dose Ursodeoxycholic Acid in Primary Biliary Cirrhosis: A Meta-analysis of Randomized Controlled Trials , 2006, The American Journal of Gastroenterology.

[11]  J. Rodés,et al.  Excellent long-term survival in patients with primary biliary cirrhosis and biochemical response to ursodeoxycholic Acid. , 2006, Gastroenterology.

[12]  F. Carrat,et al.  The effect of ursodeoxycholic acid therapy on the natural course of primary biliary cirrhosis. , 2005, Gastroenterology.

[13]  T M Therneau,et al.  A model to predict survival in patients with end‐stage liver disease , 2001, Hepatology.

[14]  A. Habior,et al.  Is serum bilirubin concentration the only valid prognostic marker in primary biliary cirrhosis? , 1999, Hepatology.

[15]  A. Burroughs,et al.  Randomised controlled trials of ursodeoxycholic-acid therapy for primary biliary cirrhosis: a meta-analysis , 1999, The Lancet.

[16]  T. Therneau,et al.  Utilization of the Mayo risk score in patients with primary biliary cirrhosis receiving ursodeoxycholic acid. , 1999, Liver.

[17]  K. Lindor,et al.  Clinical significance of serum bilirubin levels under ursodeoxycholic acid therapy in patients with primary biliary cirrhosis , 1999, Hepatology.

[18]  E. Dickson,et al.  Combined analysis of randomized controlled trials of ursodeoxycholic acid in primary biliary cirrhosis. , 1997, Gastroenterology.

[19]  B. Balkau,et al.  Ursodiol for the long-term treatment of primary biliary cirrhosis. The UDCA-PBC Study Group. , 1994, The New England journal of medicine.

[20]  P. Grambsch,et al.  Prognosis in primary biliary cirrhosis: Model for decision making , 1989, Hepatology.

[21]  F. Schaffner,et al.  Serum bilirubin: a prognostic factor in primary biliary cirrhosis. , 1979, Gut.

[22]  E. Dickson,et al.  Staging of chronic nonsuppurative destructive cholangitis (syndrome of primary biliary cirrhosis) , 1978, Virchows Archiv A.

[23]  R. Pugh,et al.  Transection of the oesophagus for bleeding oesophageal varices , 1973, The British journal of surgery.

[24]  T. Warnes.  Alkaline phosphatase. , 1972, Gut.

[25]  Thomas R Fleming,et al.  Surrogate endpoints and FDA's accelerated approval process. , 2005, Health affairs.

[26]  E. Christensen,et al.  Ursodeoxycholic Acid for Primary Biliary Cirrhosis? , 1987, The Cochrane database of systematic reviews.

[27]  M. Kaplan,et al.  Primary biliary cirrhosis. , 1987, The New England journal of medicine.

[28]  C. G. Child,et al.  Surgery and portal hypertension. , 1964, Major problems in clinical surgery.